Holen Sie sich die Stockscreener-App
16.55
2.86%
0.4575
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
Schrödinger: Surviving, If Not Thriving, In The Tricky AI Drug Discovery Field (SDGR) - Seeking Alpha
Schrodinger explores computational chemistry. Nasdaq biotech stock leans on its platform - AD HOC NEWS
Citigroup Downgrades Schrödinger (SDGR) - MSN
SDGRSchrodinger Inc Latest SEC Filings - Finviz
Form 144 Schrodinger For: 1 July By Investing.com - Investing.com India
Enterprise value to EBIT forward of Schrodinger, Inc. – NASDAQ:SDGR - TradingView
A Look at Schrodinger Inc (SDGR) After 6.6% Decline -- GF Value $26.32 vs Price $16.25 - GuruFocus
Schrodinger, Inc. Receives $57 Million from Eli Lilly’s Acquisition of Ajax Therapeutics – Key Financial Update - Minichart
Form 4 Schrodinger Inc For: 29 June By Investing.com - Investing.com South Africa
Schrodinger receives ~$57M cash payment after Eli Lilly acquisition of Ajax - TradingView
Strength Seen in Senseonics (SENS): Can Its 6.1% Jump Turn into More Strength? - Yahoo Finance
Price-Driven Insight from (SDGR) for Rule-Based Strategy - Stock Traders Daily
Schrodinger Inc (SDGR) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Schrodinger, Inc. Actuals & Estimates (SWB:43Z) - TradingView
Schrodinger, Inc. Actuals & Estimates (NASDAQ:SDGR) - TradingView
Schrodinger, Inc. Actuals & Estimates (DUS:43Z) - TradingView
SDGR Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Schrodinger Inc For: 23 June By Investing.com - Investing.com Nigeria
Schrodinger (SDGR) director receives 8,141 RSUs and 13,313 stock options - Stock Titan
Schrödinger Shareholders Expand Equity Plan, Elect Directors - TipRanks
Director Jeffrey Chodakewitz receives RSUs and options at Schrodinger (SDGR) - Stock Titan
Schrodinger (NASDAQ: SDGR) director receives RSU and stock option grants - Stock Titan
Schrodinger (NASDAQ: SDGR) director receives RSUs and stock option grant - Stock Titan
Schrodinger | 4: Statement of changes in beneficial ownership of securities-Director GINSBERG GARY L - Moomoo
Schrödinger (NASDAQ: SDGR) director receives new RSU and stock option awards - Stock Titan
Schrodinger (SDGR) grants RSUs and stock options to director Nancy Thornberry - Stock Titan
Schrodinger, Inc. (SDGR) director granted RSUs and stock options - Stock Titan
Shareholders back Schrodinger (NASDAQ: SDGR) equity plan, director slate and KPMG - Stock Titan
Morgan Stanley Maintains an Equal Weight” rating on Schrödinger, Inc. (SDGR) - Insider Monkey
SDGR: All proposals passed and strategic focus remains on AI-driven molecular discovery innovation - TradingView
12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On - Insider Monkey
Schrodinger Inc 2026 Outlook Suggests Platform-Driven Growth TrajectoryPerformance Review - dars.gov.et
Schrodinger Inc (SDGR) 2026 Outlook: Key Signals for the Drug Discovery PlatformAnalyst Coverage Count - Město Břeclav
What Does Schrodinger Inc (SDGR)’s 2026 Outlook Reveal? - Insider Monkey
Schrodinger Inc (SDGR) Eyes 2026: Software Growth and Pipeline Milestones in FocusCFO Commentary Report - dars.gov.et
Schrodinger (SDGR) Issues Restricted Stock Units to New Employees - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
(SDGR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Schrodinger Inc (SDGR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Schrodinger Inc (SDGR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Schrodinger Inc (SDGR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Schrodinger Inc (SDGR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Schrodinger Inc (SDGR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Schrodinger Inc (SDGR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Schrodinger Inc (SDGR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Schrodinger Inc (SDGR) Institutional Confidence - TradingKey
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It - Benzinga
Cheminformatics Market Size, Share | Growth Forecast [2034] - Fortune Business Insights
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates - MSN
SDGR Q1 2026 Earnings: EPS Misses Estimates as Operating Losses DeepenBuyback Announcement Report - dars.gov.et
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR) and Climb Bio (CLYM) - The Globe and Mail
Craig-Hallum Maintains Schrodinger(SDGR.US) With Buy Rating - Moomoo
SDGR Q1 2026 Earnings: EPS Misses Estimates as Company Focuses on Pipeline ProgressEarnings Acceleration Picks - lwvtexas.org
Schrödinger Finalizes Transition Terms for Former Commercial Chief - The Globe and Mail
Schrodinger finalizes separation agreement with former chief commercial officer - Investing.com
2.18%
1.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):